TNFSF10 and plasma cell myeloma: Human cells and myeloma cell lines resistant to doxorubicin, mitoxantrone, dexamethasone, and melphalan undergo apoptosis by an Apoptosis 2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) pathway [166].